tiprankstipranks
Trending News
More News >
Livzon Pharmaceutical Group Class H (HK:1513)
:1513
Hong Kong Market

Livzon Pharmaceutical Group (1513) Financial Statements

Compare
0 Followers

Livzon Pharmaceutical Group Financial Overview

Livzon Pharmaceutical Group's market cap is currently HK$30.70B. The company's EPS TTM is HK$2.475; its P/E ratio is 10.78; and it has a dividend yield of 5.51%. Livzon Pharmaceutical Group is scheduled to report earnings on March 26, 2025, and the estimated EPS forecast is HK$0.60. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue¥ 11.81B¥ 12.43B¥ 12.63B¥ 12.06B¥ 10.52B
Gross Profit¥ 7.73B¥ 7.66B¥ 8.17B¥ 7.81B¥ 6.85B
Operating Income¥ 2.84B¥ 2.42B¥ 2.35B¥ 2.27B¥ 2.50B
EBITDA¥ 3.47B¥ 3.33B¥ 3.08B¥ 2.77B¥ 2.91B
Net Income¥ 2.06B¥ 1.95B¥ 1.91B¥ 1.78B¥ 1.71B
Balance Sheet
Cash & Short-Term Investments¥ 10.92B¥ 11.41B¥ 10.52B¥ 9.33B¥ 9.98B
Total Assets¥ 24.46B¥ 25.04B¥ 24.86B¥ 22.37B¥ 20.59B
Total Debt¥ 3.93B¥ 3.48B¥ 3.62B¥ 2.69B¥ 1.93B
Net Debt-¥ -7.84B¥ -6.79B¥ -6.45B¥ -8.02B
Total Liabilities¥ 9.55B¥ 10.28B¥ 9.93B¥ 8.06B¥ 6.95B
Stockholders' Equity¥ 13.86B¥ 14.04B¥ 13.88B¥ 13.00B¥ 12.11B
Cash Flow
Free Cash Flow¥ 2.41B¥ 2.43B¥ 1.83B¥ 593.23M¥ 1.51B
Operating Cash Flow¥ 2.98B¥ 3.25B¥ 2.77B¥ 1.90B¥ 2.16B
Investing Cash Flow-¥ -708.37M---
Financing Cash Flow-----
Currency in CNY

Livzon Pharmaceutical Group Earnings and Revenue History

Livzon Pharmaceutical Group Debt to Assets

Livzon Pharmaceutical Group Cash Flow

Livzon Pharmaceutical Group Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis